This study used transcriptomic data of the TCGA-Pan-cancer cohort and GTEx dataset to reveal the SPA17 expression difference between normal human and tumor tissues, and a western blot was performed to detect the upregulated expression of SPA17 in clinical glioblastoma (GBM) samples. This evidence concerns the gene SPA17 and glioblastoma.